These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 19176057)
21. [In vitro study of effects and mechanism of rapamycin-induced autophagy in keloid fibroblasts]. Gao J; Jiao H; Cao R; Yang Z; Sun X; Zhuang Q; Xiao Z; Yan Z Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 May; 32(3):208-14. PubMed ID: 30044067 [TBL] [Abstract][Full Text] [Related]
22. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK. Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225 [TBL] [Abstract][Full Text] [Related]
23. Effect of rapamycin treatment in human seminoma TCam-2 cells through inhibition of G1-S transition. Onel T; Erdogan CS; Aru B; Yildirim E; Demirel GY; Yaba A Naunyn Schmiedebergs Arch Pharmacol; 2023 May; 396(5):1009-1018. PubMed ID: 36598515 [TBL] [Abstract][Full Text] [Related]
24. An activated mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR. Hou G; Xue L; Lu Z; Fan T; Tian F; Xue Y Cancer Lett; 2007 Aug; 253(2):236-48. PubMed ID: 17360108 [TBL] [Abstract][Full Text] [Related]
25. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways. Han S; Khuri FR; Roman J Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245 [TBL] [Abstract][Full Text] [Related]
26. The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway. Miao XY; Gu ZY; Liu P; Hu Y; Li L; Gong YP; Shu H; Liu Y; Li CL Peptides; 2013 Jan; 39():71-9. PubMed ID: 23116613 [TBL] [Abstract][Full Text] [Related]
27. TrkA is a binding partner of NPM-ALK that promotes the survival of ALK Shi W; George SK; George B; Curry CV; Murzabdillaeva A; Alkan S; Amin HM Mol Oncol; 2017 Sep; 11(9):1189-1207. PubMed ID: 28557340 [TBL] [Abstract][Full Text] [Related]
28. [Inhibitory effects of rapamycin on proliferation of chronic myelogenous leukemia cells and its mechanism]. Li J; Xue LY; Han YX; Shang YT; Yao L; Luo JM Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):843-6. PubMed ID: 23384908 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of insulin signaling and adipogenesis by rapamycin: effect on phosphorylation of p70 S6 kinase vs eIF4E-BP1. El-Chaâr D; Gagnon A; Sorisky A Int J Obes Relat Metab Disord; 2004 Feb; 28(2):191-8. PubMed ID: 14970836 [TBL] [Abstract][Full Text] [Related]
30. [The relationship of mTOR signaling pathway and histone acetylation in human gastric cancer cell lines]. Sun DF; Fang JY; Zhang YJ; Tian XQ; Zhu HY; Li EL; Gu WQ; Shen GF Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):387-91. PubMed ID: 17680526 [TBL] [Abstract][Full Text] [Related]
31. Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma. Hartman ML; Esposito JM; Yeap BY; Sugarbaker DJ J Thorac Cardiovasc Surg; 2010 May; 139(5):1233-40. PubMed ID: 19853261 [TBL] [Abstract][Full Text] [Related]
32. [Effects of mTOR Inhibitor Rapamycin on Burkitt's Lymphoma Cells]. Zhou LH; Zhu XP; Xiao HF; Xin PL; Li CT Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1397-1405. PubMed ID: 29070114 [TBL] [Abstract][Full Text] [Related]
33. Suppression of the proliferation of hypoxia-Induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF-1α/VEGF/ signaling. Liu NN; Zhao N; Cai N IUBMB Life; 2015 Jun; 67(6):446-52. PubMed ID: 25988388 [TBL] [Abstract][Full Text] [Related]
34. Rapamycin enhanced the antitumor efficacy of oxaliplatin in cisplatin-resistant ovarian cancer cells A2780cis both in vitro and in vivo. Liu J; Zhang L; Zhang X; Xing X J Chemother; 2015; 27(6):358-64. PubMed ID: 25976336 [TBL] [Abstract][Full Text] [Related]
35. Rapamycin promotes the osteoblastic differentiation of human embryonic stem cells by blocking the mTOR pathway and stimulating the BMP/Smad pathway. Lee KW; Yook JY; Son MY; Kim MJ; Koo DB; Han YM; Cho YS Stem Cells Dev; 2010 Apr; 19(4):557-68. PubMed ID: 19642865 [TBL] [Abstract][Full Text] [Related]
37. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells. Fang CX; Yang X; Sreejayan N; Ren J Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100 [TBL] [Abstract][Full Text] [Related]
38. Rapamycin Reduces Podocyte Apoptosis and is Involved in Autophagy and mTOR/ P70S6K/4EBP1 Signaling. Jin J; Hu K; Ye M; Wu D; He Q Cell Physiol Biochem; 2018; 48(2):765-772. PubMed ID: 30025409 [TBL] [Abstract][Full Text] [Related]
39. M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase. Glantschnig H; Fisher JE; Wesolowski G; Rodan GA; Reszka AA Cell Death Differ; 2003 Oct; 10(10):1165-77. PubMed ID: 14502240 [TBL] [Abstract][Full Text] [Related]
40. 5-chloro-N4-(2-(isopropylsulfonyl)phenyl)-N2-(2-methoxy-4-(4-((4-methylpiperazin-1-yl)methyl)-1H-1,2,3-triazol-1-yl)phenyl)pyrimidine-2,4-diamine (WY-135), a novel ALK inhibitor, induces cell cycle arrest and apoptosis through inhibiting ALK and its downstream pathways in Karpas299 and H2228 cells. Han M; Shen J; Wang L; Wang Y; Zhai X; Li Y; Liu M; Li Z; Zuo D; Wu Y Chem Biol Interact; 2018 Mar; 284():24-31. PubMed ID: 29458018 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]